« Not NPS? Then Whom for Shire? | Main | Fat, Dumb and Happy »

06/05/2014

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

Bruce M. Lehr

More from analyst Geoffrey Porges on how Amgen's aggressive R&D spending is bad for the company and how it should split in two to better adjust R&D risk http://www.fiercebiotech.com/story/analyst-amgens-moonshot-rd-spending-bad-business/2014-06-13

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

July 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada